These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 2350920)

  • 1. Therapeutic efficacy of two different cytostatic-linked phosphonates in combination with razoxane in the transplantable osteosarcoma of the rat.
    Klenner T; Wingen F; Keppler B; Valenzuela-Paz P; Amelung F; Schmähl D
    Clin Exp Metastasis; 1990; 8(4):345-59. PubMed ID: 2350920
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antimetastatic effects of razoxane in a rat osteosarcoma model.
    Wingen F; Spring H; Schmähl D
    Clin Exp Metastasis; 1987; 5(1):9-16. PubMed ID: 3470164
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis, antitumor activity, distribution and toxicity of 4-[4-[bis(2-chloroethyl)amino]phenyl]-1-hydroxybutane-1 1-bisphosphonic acid (BAD), a new lost derivative with increased accumulation in rat osteosarcoma.
    Wingen F; Sterz H; Blum H; Möller H; Pittermann W; Pool BL; Sinn HJ; Spring H; Schmähl D
    J Cancer Res Clin Oncol; 1986; 111(3):209-19. PubMed ID: 3525574
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of razoxane on metastases from colorectal cancer.
    Hellmann K; Gilbert J; Evans M; Cassell P; Taylor R
    Clin Exp Metastasis; 1987; 5(1):3-8. PubMed ID: 3829494
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vivo and in vitro investigations on biological effects of aromatic bis-(2-chloroethyl)amino-bisphosphonic acids, new agents proposed for chemotherapy of bone tumors: cytostatic activity in rat osteosarcoma; toxicity and genotoxicity in liver and bone marrow; mutagenicity in S. typhimurium.
    Pool BL; Berger M; Schlehofer JR; Wingen F
    Invest New Drugs; 1988 Jun; 6(2):67-78. PubMed ID: 3049432
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anticancer activity of bisphosphonic acids in methylnitrosourea-induced mammary carcinoma of the rat--benefit of combining bisphosphonates with cytostatic agents.
    Wingen F; Pool BL; Klein P; Klenner T; Schmähl D
    Invest New Drugs; 1988 Sep; 6(3):155-67. PubMed ID: 3056867
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anticancer-agent-linked phosphonates with antiosteolytic and antineoplastic properties: a promising perspective in the treatment of bone-related malignancies?
    Klenner T; Wingen F; Keppler BK; Krempien B; Schmähl D
    J Cancer Res Clin Oncol; 1990; 116(4):341-50. PubMed ID: 2152296
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cisplatin-linked phosphonates in the treatment of the transplantable osteosarcoma in vitro and in vivo.
    Klenner T; Valenzuela-Paz P; Keppler BK; Angres G; Scherf HR; Wingen F; Amelung F; Schmähl D
    Cancer Treat Rev; 1990 Sep; 17(2-3):253-9. PubMed ID: 2272041
    [No Abstract]   [Full Text] [Related]  

  • 9. Changing metastatic patterns of a transplantable rat osteosarcoma.
    Wingen F; Weber E
    Clin Exp Metastasis; 1987; 5(1):17-26. PubMed ID: 3470163
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antimetastatic Efficacy of the Combination of Caffeine and Valproic Acid on an Orthotopic Human Osteosarcoma Cell Line Model in Nude Mice.
    Igarashi K; Kawaguchi K; Kiyuna T; Murakami T; Yamamoto N; Hayashi K; Kimura H; Miwa S; Tsuchiya H; Hoffman RM
    Anticancer Res; 2017 Mar; 37(3):1005-1011. PubMed ID: 28314258
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy of CDDP and AGM-1470 chemotherapy against lung metastasis in rat osteosarcoma depends on the timing of combined administration.
    Morishita T; Mii Y; Miyauchi Y; Miura S; Honoki K; Aoki M; Kido A; Tamai S; Tsutsumi M; Konishi Y
    Jpn J Clin Oncol; 1997 Aug; 27(4):236-9. PubMed ID: 9379510
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combined vindesine and razoxane shows antimetastatic activity in advanced soft tissue sarcomas.
    Rhomberg W; Eiter H; Schmid F; Saely CH
    Clin Exp Metastasis; 2008; 25(1):75-80. PubMed ID: 17932774
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antitumor effects of two bisdioxopiperazines against two experimental lung cancer models in vivo.
    Lu DY; Xu B; Ding J
    BMC Pharmacol; 2004 Dec; 4():32. PubMed ID: 15617579
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prospective serial liver ultrasound scanning in resectable colorectal cancer treated with adjuvant razoxane.
    Taylor RH; Gilbert JM; Evans MG; Lane HG; Cassell PG
    Clin Exp Metastasis; 1984; 2(4):321-31. PubMed ID: 6399698
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intratumor chemotherapy in combination with a systemic antimetastatic drug in the treatment of Lewis-lung carcinoma.
    De-Oliveira MM; Nakamura IT; Joussef AC; Giannotti Filho O
    Braz J Med Biol Res; 1985; 18(3):293-302. PubMed ID: 3835980
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of p-F-Phe-m-bis-(2-chloroethyl)amino-L-Phe-Met-ethoxy HCl against transplantable and spontaneous murine neoplasia.
    Yagi MJ; Bekesi JG
    Cancer Chemother Pharmacol; 1990; 26(3):215-20. PubMed ID: 2357770
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of experimental colorectal cancer by razoxane (ICRF-159).
    Gilbert JM; Thompson EM; Slavin G; Kark AE
    Br J Surg; 1984 Aug; 71(8):600-3. PubMed ID: 6743979
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of AT1727 on growth and metastasis of murine tumours.
    Li XT; Hutchinson GE; Pym BA; Finch M; Hellmann K
    Eur J Cancer Clin Oncol; 1983 Feb; 19(2):283-7. PubMed ID: 6681774
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Studies in mice treated with ICRF-159 combined with daunorubicin or doxorubicin.
    Giuliani F; Casazza AM; Di Marco A; Savi G
    Cancer Treat Rep; 1981; 65(3-4):267-76. PubMed ID: 6263470
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combined razoxane and radiotherapy for melanoma brain metastases. a retrospective analysis.
    Rhomberg W; Eiter H; Boehler F; Saely C; Strohal R
    J Neurooncol; 2005 Sep; 74(3):295-9. PubMed ID: 16086112
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.